Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H24ClN2O9.Na |
Molecular Weight | 530.887 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC(Cl)=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCO)=C([O-])[C@H]2N(C)C
InChI
InChIKey=VAGGWVXDNQZWRW-XGPCLQEUSA-M
InChI=1S/C23H25ClN2O9.Na/c1-22(34)8-6-9-16(26(2)3)18(30)14(21(33)25-7-27)20(32)23(9,35)19(31)12(8)17(29)13-11(28)5-4-10(24)15(13)22;/h4-5,8-9,16,27-28,30-31,34-35H,6-7H2,1-3H3,(H,25,33);/q;+1/p-1/t8-,9-,16-,22-,23-;/m0./s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C23H24ClN2O9 |
Molecular Weight | 507.898 |
Charge | -1 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Clomocycline is the approved name of a methylol derivative of chlortetracycline. Clomocycline is a tetracycline antibiotic that is commonly prescribed by medical doctors for infections and to treat acne. It may also be used to treat urinary tract infections, gum disease, and other bacterial infections such as gonorrhea and chlamydia. Clomocycline is also used commonly as a prophylactic treatment for infection by Bacillus anthracis (anthrax). It is also effective against Yersinia pestis and malaria and is also prescribed for the treatment of Lyme disease. Clomocycline inhibits cell growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. The binding is reversible in nature. Clomocycline is lipophilic and can easily pass through the cell membrane or passively diffuses through porin channels in the bacterial membrane. This drug has been reported to be noticeably free of side-effects such as nausea, vomiting, and diarrhea.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4892122
17 mg/kg (1 capsule per 10 kg.) in a single dose or two doses taken at an interval of 6-8 hours;
34 mg/kg divided into two or three doses taken at 6-hourly intervals
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:23:49 GMT 2023
by
admin
on
Sat Dec 16 09:23:49 GMT 2023
|
Record UNII |
V4JNK46U1U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
68-20-2
Created by
admin on Sat Dec 16 09:23:49 GMT 2023 , Edited by admin on Sat Dec 16 09:23:49 GMT 2023
|
PRIMARY | |||
|
DTXSID10987414
Created by
admin on Sat Dec 16 09:23:49 GMT 2023 , Edited by admin on Sat Dec 16 09:23:49 GMT 2023
|
PRIMARY | |||
|
V4JNK46U1U
Created by
admin on Sat Dec 16 09:23:49 GMT 2023 , Edited by admin on Sat Dec 16 09:23:49 GMT 2023
|
PRIMARY | |||
|
102758
Created by
admin on Sat Dec 16 09:23:49 GMT 2023 , Edited by admin on Sat Dec 16 09:23:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
72710627
Created by
admin on Sat Dec 16 09:23:49 GMT 2023 , Edited by admin on Sat Dec 16 09:23:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |